You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pseudomonas Exotoxin

Showing 1 - 25 of 241
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Grade IV Astrocytoma, Glioblastoma Multiforme Trial in United States (MDNA55)

Completed
  • Glioblastoma
  • +3 more
  • San Francisco, California
  • +6 more
Jan 13, 2021

Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

Completed
  • Pseudomonas Infection
  • Cystic Fibrosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 3, 2022

    Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

    Not yet recruiting
    • Malignant Pleural Mesotheliomas (Mpm)
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

    Active, not recruiting
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox-tdfk
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Pancreatic Cancer Trial in Shatin (MSLN CART)

    Not yet recruiting
    • Pancreatic Cancer
    • MSLN CART
    • Shatin, N.t., Hong Kong
      Endoscopy Centre, Prince of Wales Hospital
    Sep 19, 2023

    HIV Trial in United States (Alvircept sudotox, Zidovudine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +3 more
    Oct 27, 2021

    Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

    Active, not recruiting
    Has Results
    • Hairy Cell Leukemia
    • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 13, 2022

    Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

    Recruiting
    • Urinary Bladder Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD

    Recruiting
    • Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
    • ExPEC9V
    • +2 more
    • Mechelen, Belgium
      Az Sint-Maarten
    Nov 13, 2023

    The Role of Bacteria and Genetic Variations in Cystic Fibrosis

    Completed
    • Psuedomas Infection
    • Cystic Fibrosis
      • Bethesda, Maryland
      • +3 more
      Jun 25, 2021

      Modification of Antibiotic Susceptibility Testing on Antibiotic

      Recruiting
      • Antibiotic Resistant Infection
      • Vandoeuvre les nancy, France
        CHRU Nancy
      Jun 12, 2023

      Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)

      Approved for marketing
      • Relapsed/Refractory Hairy Cell Leukemia
      • Moxetumomab Pasudotox
      • (no location specified)
      Jun 26, 2020

      Modifications to Rendering of Antibiogram on Prescriptions of

      Recruiting
      • Pseudomonas
        • Strasbourg, France
          Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
        Oct 30, 2023

        Extraintestinal Pathogenic Escherichia Coli Prevention Trial in Worldwide (ExPEC10V, ExPEC4V, Prevnar 13)

        Active, not recruiting
        • Extraintestinal Pathogenic Escherichia Coli Prevention
        • ExPEC10V
        • +3 more
        • Huntsville, Alabama
        • +28 more
        Jan 17, 2023

        Cystic Fibrosis Trial in Pittsburgh (sodium nitrite)

        Active, not recruiting
        • Cystic Fibrosis
        • sodium nitrite
        • Pittsburgh, Pennsylvania
        • +1 more
        Jul 7, 2022

        Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

        Active, not recruiting
        Has Results
        • Adult T-Cell Leukemia (ATL)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jan 13, 2022

        Diabetic Foot Infection Trial (TP-102, Placebo)

        Not yet recruiting
        • Diabetic Foot Infection
        • TP-102
        • Placebo
        • (no location specified)
        Jul 6, 2023

        Isolation of Human Recombinant Therapeutic Monoclonal

        Recruiting
        • Pseudomonas Aeruginosa
        • Multi-antibiotic Resistance
        • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
        • Grenoble, France
          Chu Grenoble Alpes
        May 6, 2022

        Breast Cancer, Breast Cancer Female, Genetic Predisposition to Disease Trial in San Francisco (Cephalexin)

        Recruiting
        • Breast Cancer
        • +2 more
        • San Francisco, California
          University of California, San Francisco
        Feb 22, 2022

        Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection Trial in Farmington, Tyler (AP-PA02, Placebo)

        Recruiting
        • Non-cystic Fibrosis Bronchiectasis
        • +2 more
        • AP-PA02
        • Placebo
        • Farmington, Connecticut
        • +1 more
        Jan 13, 2023

        Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

        Recruiting
        • Bladder Cancer
        • Pseudomonas aeruginosa
        • Jinan, Shandong, China
          Qilu hospital
        Jul 26, 2023

        Trikafta/Kaftrio and Pseudomonas Aeruginosa

        Recruiting
        • Cystic Fibrosis
          • Milan, Italy
          • +1 more
          Jan 9, 2023

          Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection Trial (Rapid Diagnostics)

          Not yet recruiting
          • Blood Stream Infections
          • +4 more
          • Rapid Diagnostics
          • (no location specified)
          Jul 31, 2023

          Affecting Progression of Bronchiectasis

          Recruiting
          • Bronchiectasis
          • Pseudomonas aeruginosa colonization infection
          • Macrolides
          • Wuhan, Hubei, China
            Wuhan Union Hospital
          Feb 7, 2023

          Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas Trial in United States (AP-PA02, Placebo)

          Active, not recruiting
          • Cystic Fibrosis
          • +4 more
          • AP-PA02
          • Placebo
          • Los Angeles, California
          • +19 more
          Dec 20, 2022